Enhanced immune responses following heterologous vaccination with self-amplifying RNA and mRNA COVID-19 vaccines. (2022)
Attributed to:
saRNA SARS-CoV-2 vaccine
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1371/journal.ppat.1010885
PubMed Identifier: 36194628
Publication URI: http://europepmc.org/abstract/MED/36194628
Type: Journal Article/Review
Volume: 18
Parent Publication: PLoS pathogens
Issue: 10
ISSN: 1553-7366